Authors

• Martina Goetsch
• Andrés Yarur (ORCID: https://orcid.org/0000-0003-2293-5555)
• Julián Panés (ORCID: https://orcid.org/0000-0002-4971-6902)
• Christina Ha (ORCID: https://orcid.org/0000-0003-3897-7370)
• Raymond Cross
• Jessica Ravikoff Allegretti (ORCID: https://orcid.org/0000-0003-3585-2425)
• Michael Chiorean (ORCID: https://orcid.org/0000-0002-4238-9988)
• Arcangelo M. Abbatemarco
• Alexis B Dalam
• David Blanco
• Joseph Wu (ORCID: https://orcid.org/0009-0006-3464-2556)
• Aoibhinn McDonnell (ORCID: https://orcid.org/0000-0002-2229-0382)

Institutions

• Cedars-Sinai Medical Center (US)
• Brigham and Women's Hospital (US)
• Mercy Medical Center (US)
• Harvard University (US)
• Pfizer (United States) (US)
• Pfizer (United Kingdom) (GB)
• Swedish Medical Center (US)
• Swedish Medical Center (US)
• Pfizer (Switzerland) (CH)
• Hospital Clínic de Barcelona (ES)
• Mayo Clinic in Arizona (US)
• Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
• Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)

Publication Details

Journal

Inflammatory Bowel Diseases

Published

2024-12-13

DOI

https://doi.org/10.1093/ibd/izae288

Citations

2

Primary Topic

Inflammatory Bowel Disease

Type

article

Field-Weighted Citation Impact

1.10

Funders

• Bristol-Myers Squibb
• Pfizer
• Sanofi
• Celgene
• Leona M. and Harry B. Helmsley Charitable Trust
• Celltrion
• Seres Therapeutics
• Bausch Health
• Genentech
• Samsung